Jul. 3 at 10:50 PM
Morgan Stanley reiterated its Overweight rating and
$103 price target on Monster Beverage, saying the company's strongest-ever product innovation pipeline positions it for sustained growth. Products launched since late 2025 now account for about 14.5% of U.S. scanned sales, up from virtually zero last September, reflecting what the firm described as Monster's most powerful innovation cycle to date.
The broker expects the expanded product lineup—including Ultra Red, White and Blue Razz, Juice Monster Strawberry Lemonade, Strawberry Shots, the FLRT brand, the relaunch of Storm, and U.S. launches of Lando Norris Zero Sugar and Juice Monster Bad Apple—to drive near-term revenue growth while supporting long-term market share gains. Unlike prior launches focused mainly on new flavors, the current strategy spans multiple beverage categories and consumer segments.
$MNST